Human Gene MIR421 (ENST00000365696.4) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
DI443572 - KR 1020140074997-A/193: MICRORNAS IN NEURODEGENERATIVE DISORDERS. DM176541 - A nucleics Acid regulating cell growth. HW807898 - JP 2014534810-A/193: MICRORNAS IN NEURODEGENERATIVE DISORDERS. HZ408442 - JP 2015528002-A/1039: CHIRAL CONTROL. LG051776 - KR 1020150036642-A/1042: CHIRAL CONTROL. DI443571 - KR 1020140074997-A/192: MICRORNAS IN NEURODEGENERATIVE DISORDERS. DM176465 - A nucleics Acid regulating cell growth. FW312195 - DETECTING NUCLEIC ACIDS. FW364294 - Oligonucleotides for modulating target RNA activity. HI965102 - Sequence 387 from Patent WO2010139812. HI966410 - Sequence 730 from Patent WO2010139811. HI967276 - Sequence 730 from Patent WO2010139810. HV595203 - JP 2010539959-A/584: Micromirs. HW807897 - JP 2014534810-A/192: MICRORNAS IN NEURODEGENERATIVE DISORDERS. HZ074538 - JP 2013535982-A/629: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ082794 - JP 2015513906-A/151: Stem Cell Microparticles. HZ157760 - JP 2015130862-A/584: Micromirs. HZ186607 - JP 2015146814-A/356: Oligonucleotides for modulating target RNA activity. HZ436575 - JP 2015529450-A/151: Stem Cell Microparticles. HZ480458 - JP 2015535430-A/964: TERMINALLY MODIFIED RNA. HZ790389 - JP 2016504050-A/2134: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401140 - Sequence 387 from Patent WO2011080318. JA402118 - Sequence 387 from Patent WO2011080315. JA403125 - Sequence 387 from Patent WO2011080316. JA405756 - Sequence 387 from Patent EP2336353. JA427253 - Sequence 586 from Patent WO2011072177. JA429282 - Sequence 387 from Patent WO2011095623. JA791640 - Sequence 42 from Patent WO2012089772. JB022517 - Sequence 359 from Patent WO2013026685. JB023062 - Sequence 316 from Patent WO2013026684. JB050134 - Sequence 221 from Patent WO2013020926. JB074867 - Sequence 127 from Patent WO2012168448. JB620723 - Sequence 703 from Patent WO2013063544. JC171779 - Sequence 151 from Patent WO2013150303. JC513121 - Sequence 3374 from Patent WO2014113089. JC572590 - Sequence 151 from Patent WO2014125276. JC582278 - Sequence 151 from Patent WO2014125277. JE953974 - Sequence 151 from Patent WO2015052526. JE955727 - Sequence 151 from Patent WO2015052527. LF137479 - JP 2016507550-A/151: Method of Producing Microparticles. LF161350 - JP 2016513950-A/1416: Oligomers with improved off-target profile. LF162444 - JP 2016513095-A/151: Stem Cell Microparticles and miRNA. LF953196 - JP 2016534103-A/151: Stem Cell Microparticles and miRNA. LG005541 - KR 1020150004822-A/151: STEM CELL MICROPARTICLES. LG053237 - KR 1020150059168-A/151: STEM CELL MICROPARTICLES. LG240476 - KR 1020160035087-A/151: STEM CELL MICROPARTICLES AND MIRNA. LP714647 - Sequence 19 from Patent WO2015092707. LP715538 - Sequence 59 from Patent WO2016001030. LP727036 - Sequence 730 from Patent EP2883966. LP769515 - Sequence 42 from Patent EP3294910. LP819306 - Sequence 730 from Patent EP3296406. LP939248 - Sequence 730 from Patent EP3184651. LP951888 - Sequence 394 from Patent WO2017157650. LQ070709 - Sequence 1033 from Patent EP2964234. LQ278582 - Sequence 121 from Patent WO2016066288. LQ441120 - Sequence 127 from Patent EP3029157. LV470561 - JP 2016534036-A/151: Stem Cell Microparticles and miRNA. LY405268 - KR 1020160117535-A/573: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY416923 - KR 1020160145093-A/29: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY. LZ233964 - JP 2017184756-A/356: Oligonucleotides for modulating target RNA activity. MA260507 - JP 2017505623-A/573: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA400855 - JP 2018515097-A/42: Method for Diagnosis and Prognosis of Chronic Heart Failure. MA405812 - WO 2018155427-A/586: A probe with reduced false positive binding, a method to desing the probe, and the use thereof. MA644210 - JP 2017113010-A/2134: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA732094 - JP 2017140048-A/964: TERMINALLY MODIFIED RNA. MP015318 - Sequence 521 from Patent WO2019016252. MS673513 - Sequence 316 from Patent EP3135774. MS834241 - Sequence 387 from Patent EP3112479. MS901886 - Sequence 359 from Patent EP3156505. MS930526 - Sequence 19 from Patent EP3178943. MA801263 - JP 2018183181-A/2134: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129251 - Sequence 151 from Patent EP3470073. MP162174 - Sequence 151 from Patent WO2019069093. MP395043 - Sequence 141 from Patent EP3565903.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: ENST00000365696.1, ENST00000365696.2, ENST00000365696.3, NR_030398, uc022bzb.1, uc022bzb.2, uc022bzb.3 UCSC ID: ENST00000365696.4 RefSeq Accession: NR_030398
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|